TICKERNOMICS Sign up
Last Update: 2023-12-23 05:57:21
THERMO FISHER SCIENTIFIC INC. ( TMO ) https://www.thermofisher.com
526.56USD
Sector:
Healthcare
Industry:
Diagnostics & Research
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-2.35%
TMO
SPY
30.72%
TMO
15.93%
SPY
112.82%
TMO
157.36%
SPY
201.04%
TMO
410.32%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
204305.28
244382.28
1.02
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
32.35
4.68
4.49
3.27
0.27
22.77
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
17.63
41.89
24.72
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.586
7.61
8.50
0.90
Other Earnings and Cash Flow Stats:
THERMO FISHER SCIENTIFIC INC. ( TMO ) Net Income TTM ($MM) is 6075.00
THERMO FISHER SCIENTIFIC INC. ( TMO ) Operating Income TTM ($MM) is 6998.00
THERMO FISHER SCIENTIFIC INC. ( TMO ) Owners' Earnings Annual ($MM) is 0.00
THERMO FISHER SCIENTIFIC INC. ( TMO ) Current Price to Owners' Earnings ratio is 0.00
THERMO FISHER SCIENTIFIC INC. ( TMO ) EBITDA TTM ($MM) is 10934.00
THERMO FISHER SCIENTIFIC INC. ( TMO ) EBITDA Margin is 24.72%
Capital Allocation:
THERMO FISHER SCIENTIFIC INC. ( TMO ) has paid 1.40 dividends per share and bought back 7.0 million shares in the past 12 months
THERMO FISHER SCIENTIFIC INC. ( TMO ) has increased its debt by 9909.0 million USD in the last 12 months
Capital Structure:
THERMO FISHER SCIENTIFIC INC. ( TMO ) Interest-bearing Debt ($MM) as of last quarter is 40079
THERMO FISHER SCIENTIFIC INC. ( TMO ) Annual Working Capital Investments ($MM) are -3618
THERMO FISHER SCIENTIFIC INC. ( TMO ) Book Value ($MM) as of last quarter is 45464
THERMO FISHER SCIENTIFIC INC. ( TMO ) Debt/Capital as of last quarter is 88%
Other Balance Sheet Stats:
THERMO FISHER SCIENTIFIC INC. ( TMO ) has 6151 million in cash on hand as of last quarter
THERMO FISHER SCIENTIFIC INC. ( TMO ) has 14158 million of liabilities due within 12 months, and long term debt 35284 as of last quarter
THERMO FISHER SCIENTIFIC INC. ( TMO ) has 388 common shares outstanding as of last quarter
THERMO FISHER SCIENTIFIC INC. ( TMO ) has 0 million USD of preferred stock value
Academic Scores:
THERMO FISHER SCIENTIFIC INC. ( TMO ) Altman Z-Score is 3.83 as of last quarter
THERMO FISHER SCIENTIFIC INC. ( TMO ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
THERMO FISHER SCIENTIFIC INC. ( TMO ) largest shareholder is State Street Corporation owning 15641589 shares at 8236.24 ($MM) value
Josh Gottheimer(an insider) Sold 0 shares of THERMO FISHER SCIENTIFIC INC. ( TMO ) for the amount of $0.00 on 2023-11-28
0.19% of THERMO FISHER SCIENTIFIC INC. ( TMO ) is held by insiders, and 91.80% is held by institutions
THERMO FISHER SCIENTIFIC INC. ( TMO ) went public on 1978-01-13
Other THERMO FISHER SCIENTIFIC INC. ( TMO ) financial metrics:
FCF:6854.00
Unlevered Free Cash Flow:0.00
EPS:17.68
Operating Margin:17.63
Gross Profit Margin:41.89
Div. Payout Ratio%:8.60
Div. Growth YoY%:20.69
Equity Return%:15.13
Beta:0.90
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About THERMO FISHER SCIENTIFIC INC. ( TMO ) :
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.